41 research outputs found
Contribution of Neurogenic and Allergic Ways to the Pathophysiology of Nonallergic Rhinitis
Background: A neuroallergic interaction was reported in the pathogenesis of allergic rhinitis (AR), but the pathophysiology of nonallergic rhinitis (NAR) is poorly understood. We aimed to explore the contribution of neuroallergic mechanisms to the pathogenesis of NAR. Methods: Subjects were divided into three groups - NAR patients (n = 25), AR patients (n = 16) and the control group (n = 10) - and were assessed using the nasal provocation test (NPT) with house dust mite. Total symptom scores, nasal inspiratory peak flow and nasal lavage were performed before and after NPT. Nasal brushing and scraping was done after NPT. Results: NPT was positive in NAR (52%) and AR (100%) patients and negative in all controls. After NPT, total symptom scores increased in both rhinitis groups. Post-NPT values of nasal inspiratory peak flow decreased only in AR patients. NAR patients showed a similar inflammatory cell profile in the nasal smears to AR patients which was different in controls. There were more tryptase- and immunoglobulin E (IgE)-positive cells in the nasal mucosa of AR patients, and more substance-p-positive cells were observed in NAR patients compared with controls. However, IgE- and tryptase-positive cells in NAR patients and substance-p-positive cells in AR patients were detectable in nasal mucosa, but rarely in the controls. Comparing the values before and after NPT, tryptase significantly increased in the nasal lavages of AR and NAR patients, while house dust mite-specific IgE did not change. Conclusions: We showed the existence of a common pathophysiological mechanism with different contributions in AR and NAR. We conclude that the difference in dominance of neuroallergic ways may determine the major phenotype of rhinitis. Copyright (C) 2012 S. Karger AG, BaselKirikkale University Projects of Scientific ResearchesKirikkale University [2007/4]This work was supported by a grant from Kirikkale University Projects of Scientific Researches (grant No. 2007/4) which was received by Baccioglu Kavut and Fusun Kalpaklioglu
Does Serum Leptin Differ Between Patients With Rhinitis Of Allergic Vs Nonallergic Aetiology?
Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI) -- FEB 28-MAR 04, 2014 -- San Diego, CA…Amer Acad Allergy Asthma & Immuno
Asthma as a Comorbid Disease in COVID-19
Bavbek, Sevim/0000-0002-7884-0830Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus disease 2019 (COVID-19). In terms of asthma and COVID-19, there is also a risk of experiencing an asthma exacerbation triggered by coronavirus infection beyond the direct risk of the infection itself. As a comorbid disease, the prevalence of COVID-19 infection in asthma patients is not clear. In addition, the influence of asthma on the severity of COVID-19 has not been reported. The aim of this review was to summarize the reported worldwide data about the prevalence and the clinical characteristics of patients with asthma during COVID-19 infection
Rationale for the autologous serum skin test in acute versus chronic urticaria
Introduction: Autologous serum skin test (ASST) is a rapid, in-vivo clinical test to detect functional autoantibodies in patients with chronic spontaneous urticaria (CSU), but the rationale for its use in acute urticaria (AU) is unknown. Aim: To evaluate the efficacy of ASST among patients with AU or CSU. Material and methods: Treatment-naIve adult (age >= 18 years) patients with a diagnosis of AU ( 100 IU/ml) in AU (85.2%) and CSU (65.2%) groups was similar (p = 0.06), but significantly higher than in the control group (10.7%) (p < 0.001 and p < 0.001). The CSU group had significantly higher abnormal thyroid test results (45.7%) than AU (14.8%) and control groups (3.6%) (p = 0.01 and p < 0.001), whereas patients with clinically diagnosed thyroiditis were only in the CSU group (6.5%). In logistic regression analysis, there was no relation found among the possible risk factors for ASST, even if analysed separately as AU, CSU and control groups. Conclusions: Even though thyroid function test levels were found to be related with CSU, and total IgE was associated with urticaria, ASST was found to be of importance. This study confirms that ASST was insufficient to demonstrate autoimmunity and acute-chronic urticaria nature. Further tests indicating auto-antibodies in AU and CSU are needed
Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis
65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology -- MAR 13-17, 2009 -- Washington, DCBackground: Intranasal antihistamine has not been thoroughly studied in the treatment of rhinitis of different etiologies. This study was designed to show the comparative efficacy of nasal antihistamine and nasal corticosteroid in patients with allergic rhinitis (AR) and nonallergic rhinitis (NAR). Methods: A comparison of the efficacy of azelastine nasal spray (AZENS) versus triamcinolone acetonide nasal spray (TANS) on total nasal symptom scores (TNSS), nasal peak inspiratory flow rate (nPIFR), and nasal cytology was studied in a 2-week randomized parallel-group trial. The Epworth Sleepiness Scale (ESS) and health-related quality of life (HRQoL) were also analyzed. Results: The study group consisted of 132 patients (100 women and 32 men) with a mean age of 33.14 +/- 12.52 years, Sixty-nine patients had AR and 63 had NAR. Although TNSS including sneezing, itching, rhinorrhea, congestion-but not anosmia-significantly improved in both groups, intranasal azelastine reduced ocular symptoms greatly compared with intranasal triamcinolone (p = 0.05). Patients with NAR seemed to respond more to TANS, whereas AZENS was more useful in AR. The nPIFR improved in AR and NAR, with no significant difference between the treatment groups. Neither intranasal azelastine nor intranasal triamcinolone changed cytology in nasal lavage. Both medications were well tolerated, but AZENS led to more adverse events than TANS (56.9 and 19%, respectively; p = 0.001), mainly because of bitter taste. Scores on each domain of generic HRQoL (36-Item Short-Form Health Survey) and mini-rhinitis QoL questionnaires, as well as ESS score, significantly improved in both groups, irrespective of rhinitis etiology. Conclusion: In this first comparative demonstration, AZENS appears to be as effective as triamcinolone in symptom scores, nPIFR, ESS, and HRQoL, equally in AR and NAR. (Am J Rhinol Allergy 24, 29-33, 2010; doi: 10.2500/ajra.2010.24.3423)Amer Acad Allergy Asthma & Immunol (AAAAI
Diagnostic tools for allergic rhinitis and asthma
The diagnosis of allergic airway diseases is based on symptoms, and the laboratory tests help us to classify the types. A correct diagnose is important, since the treatment will change in different types of diseases. For example, untreated rhinitis may result in other diseases like asthma, and deteriorate the quality of life. Therefore, early diagnosis of allergic airway diseases is important before the disease progresses. This review summarizes the currently known diagnostic tools which can be useful in daily practical life and researches, including assessment of symptoms, physical examination, allergy skin tests, total and specific IgE, nasal provocation test and assessment parameters (symptoms, nasal flow and secretions), nasal mucosal sampling, and pulmonary function test
Characteristics of nonallergic rhinitis
Nonallergic rhinitis (NAR) is a type of rhinitis with perennial symptoms, unknown aetiology, and no clear treatment suggestions. Even though NAR has similarities with allergic rhinitis with regards to its prevalence, symptoms and impairment on quality of life, its importance is underestimated in clinical practice. There is no single valid test for the diagnosis of NAR as typical rhinitis symptoms, negativity in allergy skin tests and/or specific IgE, and exclusion of nonallergic rhinitis types with known aetiology are required. Pathophysiology of NAR is poorly understood, but a key component involves activation of neurogenic or allergic pathways. The aim of this review was to describe the characteristics, diagnostic methods, prevalence, pathophysiology, and treatment of NAR in the light of recent publications
The Prevalence of Allergic Diseases and Associated Risk Factors in School-Age Children and Adults in Erzurum, Turkey
OBJECTIVES: Allergic diseases are a major public health problem, owing to their socioeconomic burden and high frequency. The aim of this study was to assess the prevalence and risk factors of allergic diseases in adults and children in the province of Erzurum
False-positive PET-CT scan secondary to interstitial pneumonitis mimicking malignancy in fire eater's lung
28th International Congress of the European-Respiratory-Society (ERS) -- SEP 15-19, 2018 -- Paris, FRANCEInhalation of flammable oily hydrocarbons may cause interstitial pneumonitis by diffusion throughout the bronchial mucosa and alveoli.
A 70 year old male was admitted with progressive dyspnoea, fever, haemoptysis, cough, and sputum for 6 weeks. Physical examination revealed fine crackles on the right side of thorax, and O2 sat: 94%. He had performed fire-eating show 6 weeks ago. Chest x-ray showed irregular opacity on the right lower zone. Thorax computed tomography (CT) was reported a mass (12x11mm) located in the medial and right lower lobe, surrounded the middle lobe bronchus and pulmonary vein, invades to the hilar area, and diaphragm, and surrounded with multiple nodules. Parenteral antibiotic was given since he had leucocytosis, elevated procalsitonin, and sedimentation (111/hr). After 4 weeks, positron emission tomography (PET)-CT was resulted as right hilar lymphadenopathy (19x22mm, SUV: 5), and mass (53x77mm, SUV: 8.7) with satellite nodules and ground glass opacity. Diagnostic bronchoscopy revealed erythema and narrowing of the entrance of medial lobe. Bronchial lavage (BL), and bronchial mucosa biopsy was negative for any pathogens, and malignancy. Transthoracic needle lung biopsy was consistent with “interstitial pneumonitis”. Oral corticosteroid was started as 1mg/kg/day, and gradually tapered in 3 months. Finally, his clinical findings were improved, as well as radiologic abnormalities.
This case illustrates the importance of considering interstitial pneumonitis in fire eaters even some findings are incompliant such as false-posivitiy in PET-CT, and no demonstration of lipid laden macrophages in BL.European Respiratory So
